These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9465025)

  • 1. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.
    Watanabe H; Pan ZQ; Schreiber-Agus N; DePinho RA; Hurwitz J; Xiong Y
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1392-7. PubMed ID: 9465025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
    Lee MH; Reynisdóttir I; Massagué J
    Genes Dev; 1995 Mar; 9(6):639-49. PubMed ID: 7729683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
    Matsuoka S; Edwards MC; Bai C; Parker S; Zhang P; Baldini A; Harper JW; Elledge SJ
    Genes Dev; 1995 Mar; 9(6):650-62. PubMed ID: 7729684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.
    Luo Y; Hurwitz J; Massagué J
    Nature; 1995 May; 375(6527):159-61. PubMed ID: 7753174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
    Joaquin M; Watson RJ
    J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New functional activities for the p21 family of CDK inhibitors.
    LaBaer J; Garrett MD; Stevenson LF; Slingerland JM; Sandhu C; Chou HS; Fattaey A; Harlow E
    Genes Dev; 1997 Apr; 11(7):847-62. PubMed ID: 9106657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
    Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
    Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role for the 310 helix region of p57(Kip2) in cyclin-dependent kinase 2 inhibition and growth suppression.
    Hashimoto Y; Kohri K; Kaneko Y; Morisaki H; Kato T; Ikeda K; Nakanishi M
    J Biol Chem; 1998 Jun; 273(26):16544-50. PubMed ID: 9632724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G; Hunter T; Ruoslahti E
    Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
    Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
    J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of p27KIP1 in the proliferation of the developing corneal endothelium.
    Yoshida K; Kase S; Nakayama K; Nagahama H; Harada T; Ikeda H; Harada C; Imaki J; Ohgami K; Shiratori K; Ilieva IB; Ohno S; Nishi S; Nakayama KI
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2163-7. PubMed ID: 15223790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101.
    Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B
    Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development.
    Zhang P; Wong C; DePinho RA; Harper JW; Elledge SJ
    Genes Dev; 1998 Oct; 12(20):3162-7. PubMed ID: 9784491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of the Cip/Kip family.
    Hengst L; Reed SI
    Curr Top Microbiol Immunol; 1998; 227():25-41. PubMed ID: 9479824
    [No Abstract]   [Full Text] [Related]  

  • 17. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arresting developments in the cardiac myocyte cell cycle: role of cyclin-dependent kinase inhibitors.
    Brooks G; Poolman RA; Li JM
    Cardiovasc Res; 1998 Aug; 39(2):301-11. PubMed ID: 9798515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cyclin-dependent kinase inhibitor p27(Kip1) induces N-terminal proteolytic cleavage of cyclin A.
    Bastians H; Townsley FM; Ruderman JV
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15374-81. PubMed ID: 9860976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.